Laurindo LF, Barbalho SM, Guiguer EL, da Silva Soares M, de Souza GA, Fidalgo TM, Araujo AC, de Souza Gonzaga HF, de Bortoli Teixeira D, de Silva Ullmann O, Sloan T, Sloan KP LA (2022) GLP-1a: going beyond traditional use
Lilly Investors
A GLP-1 plan may include medical history review, goal setting, medication selection, nutrition guidance, side-effect planning, supplement review when appropriate, and follow-up visits to adjust the plan safely
Early detection of adverse reactions prevents unnecessary treatment continuation and patient discomfort from extended exposure to therapy [41]
5 Some common GLP-1 and mixed GLP-1 receptor agonists that are in trials for AUD include exenatide (Byetta and Bydureon), liraglutide (Victoza and Saxenda), dulaglutide (Trulicity), and semaglutide (Ozempic) and tirzepatide (Mounjaro)